Jean-Pierre Sommadossi

Insider Reports History

Location
Boston, MA
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Jean-Pierre Sommadossi
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jean-Pierre Sommadossi:

Company Role Class Num Shares Value Price $ Report Date Ownership
Atea Pharmaceuticals, Inc. President, CEO, and Chairman, Director Common Stock 5,866,025 $20,941,709 $3.57 31 Jan 2026 Held by JPM Partners LLC
Atea Pharmaceuticals, Inc. President, CEO, and Chairman, Director Common Stock 767,830 $952,109 $1.24 03 Feb 2026 Direct
Atea Pharmaceuticals, Inc. President, CEO, and Chairman, Director Restricted Stock Units 0 $304,525 $3.06 31 Jan 2026 Direct
Kezar Life Sciences, Inc. Director Stock Option (Right to Buy) 26,000 28 Jun 2021 Direct
ABG Acquisition Corp. I Director Class B ordinary shares 0 01 Mar 2023 Direct
Atea Pharmaceuticals, Inc. President, CEO, and Chairman, Director Stock Option (Right to Buy) 0 03 Feb 2026 Direct

Insider Reports Filed by Jean-Pierre Sommadossi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2026 6 -$77,834 4 President, CEO, and Chairman, Director 03 Feb 2026, 19:46
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2025 6 -$271,119 4 President, CEO, and Chairman, Director 04 Feb 2025, 18:00
AVIR Atea Pharmaceuticals, Inc. 17 Sep 2024 3 -$234,155 4 President, CEO, and Chairman, Director 19 Sep 2024, 20:02
AVIR Atea Pharmaceuticals, Inc. 05 Jun 2024 1 -$4,024 4 President, CEO, and Chairman, Director 07 Jun 2024, 18:34
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2024 4 -$218,819 4 President, CEO, and Chairman, Director 02 Feb 2024, 21:30
/report/000089924323006943-sommadossi-jean-pierre-2023-03-01 ABG Acquisition Corp. I 01 Mar 2023 1 $0 4 Director 03 Mar 2023, 15:00
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2023 2 $0 4 President, CEO, and Chairman, Director 02 Feb 2023, 17:33
AVIR Atea Pharmaceuticals, Inc. 31 Jan 2022 1 $0 4 President, CEO, and Chairman, Director 02 Feb 2022, 16:15
KZR Kezar Life Sciences, Inc. 28 Jun 2021 1 $0 4 Director 30 Jun 2021, 18:49